These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3980104)

  • 1. Present status of clinical studies of Fluosol-DA (20%) in Japan.
    Mitsuno T; Ohyanagi H
    Int Anesthesiol Clin; 1985; 23(1):169-84. PubMed ID: 3980104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent studies on perfluorochemical (PFC) emulsion as an oxygen carrier in Japan.
    Mitsuno T; Ohyanagi H; Yokoyama K; Suyama T
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):365-73. PubMed ID: 3052644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients.
    Suyama T; Yokoyama K; Naito R
    Prog Clin Biol Res; 1981; 55():609-28. PubMed ID: 7027272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical use of fluosol-DA in Jehovah's Witness patients.
    Ohyanagi H; Nakaya S; Okumura S; Saitoh Y
    Artif Organs; 1984 Feb; 8(1):10-8. PubMed ID: 6703920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%).
    Tremper KK; Lapin R; Levine E; Friedman A; Shoemaker WC
    Crit Care Med; 1980 Dec; 8(12):738-41. PubMed ID: 7449405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluosol-DA as a red-cell substitute in acute anemia.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Langdale LA; Krause LM; Rice CL; Chamberlin WH; Moss GS
    N Engl J Med; 1986 Jun; 314(26):1653-6. PubMed ID: 3713771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA.
    Tremper KK; Friedman AE; Levine EM; Lapin R; Camarillo D
    N Engl J Med; 1982 Jul; 307(5):277-83. PubMed ID: 7045667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial Canadian experience with artificial blood (Fluosol-DA-20%) in severely anemic patients.
    Stefaniszyn HJ; Wynands JE; Salerno TA
    J Cardiovasc Surg (Torino); 1985; 26(4):337-42. PubMed ID: 4019576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental studies on fluosol DA administration in acute pancreatitis.
    Ohyanagi H; Ohashi O; Nakayama S; Yamamoto M; Okumura S; Saitoh Y
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):585-94. PubMed ID: 3179491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a perfluorochemical emulsion as a blood gas carrier.
    Mitsuno T; Ohyanagi H; Yokoyama K
    Artif Organs; 1984 Feb; 8(1):25-33. PubMed ID: 6422912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with Fluosol-DA.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Moss GS
    Prog Clin Biol Res; 1983; 122():331-42. PubMed ID: 6878375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with Fluosol-DA (20%) in the United States.
    Tremper KK; Levine EM; Waxman K
    Int Anesthesiol Clin; 1985; 23(1):185-97. PubMed ID: 3884514
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA) Summary of 186 cases.
    Mitsuno T; Ohyanagi H; Naito R
    Ann Surg; 1982 Jan; 195(1):60-9. PubMed ID: 7034658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. U.S. clinical studies of the treatment of anemia with fluosol-DA 20%.
    Tremper KK; Cullen BF
    Artif Organs; 1984 Feb; 8(1):19-24. PubMed ID: 6367719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial results of a clinical trial of Fluosol-DA 20 percent in acute cerebral ischemia.
    Swann KW; Ropper AH; Zervas NT
    Prog Clin Biol Res; 1983; 122():399-404. PubMed ID: 6348787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%) on cerebral circulation in the monkey.
    Nagasawa S; Handa H; Naruo Y; Oda Y; Yonekawa Y; Takebe Y
    Neurol Res; 1981; 3(3):237-50. PubMed ID: 6122175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of blood and Fluosol-DA for cardiopulmonary bypass.
    Rousou JA; Engelman RM; Anisimowicz L; Dobbs WA
    J Cardiovasc Surg (Torino); 1985; 26(5):447-53. PubMed ID: 4030876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of hemodynamics and O2 transport associated with the perfluorochemical blood substitute, Fluosol-DA.
    Nishimura N; Sugi T
    Crit Care Med; 1984 Jan; 12(1):36-8. PubMed ID: 6690204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of Fluosol-DA in acute cerebral ischemia.
    Peerless SJ; Ishikawa R; Hunter IG; Peerless MJ
    Stroke; 1981; 12(5):558-63. PubMed ID: 6795765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective effect of fluosol-DA in acute cerebral ischemia (author's transl)].
    Ishikawa R; Peerless SJ; Hunter IG
    No Shinkei Geka; 1981 Dec; 9(13):1503-8. PubMed ID: 6808409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.